These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Ketoconazole and gynecomastia. Moncada B; Baranda L J Am Acad Dermatol; 1982 Oct; 7(4):557-8. PubMed ID: 6128355 [No Abstract] [Full Text] [Related]
25. Ketoconazole effects. Stevens DA; William PL; Sugar AM; Pont A Ann Intern Med; 1982 Aug; 97(2):284-5. PubMed ID: 6285789 [No Abstract] [Full Text] [Related]
28. A multicenter double-blind evaluation of ketoconazole in the treatment of dermatomycoses. Jolly HW; Daily AD; Rex IH; Krupp I; Tromovitch TA; Stegman SJ; Glogau R Cutis; 1983 Feb; 31(2):208-10, 212-3 passim. PubMed ID: 6299652 [TBL] [Abstract][Full Text] [Related]
29. [Ketoconazole]. Cuena Boy R; Azanza Perea JR; Honorato Pérez JM Rev Med Univ Navarra; 1982 Sep; 26(3):193-4. PubMed ID: 6302808 [No Abstract] [Full Text] [Related]
30. Ketoconazole approved for systemic fungal infections. FDA Drug Bull; 1981 Nov; 11(3):18-9. PubMed ID: 6274725 [No Abstract] [Full Text] [Related]
31. Ketoconazole blocks testosterone synthesis. Pont A; Williams PL; Azhar S; Reitz RE; Bochra C; Smith ER; Stevens DA Arch Intern Med; 1982 Nov; 142(12):2137-40. PubMed ID: 6291475 [TBL] [Abstract][Full Text] [Related]
32. Proceedings of the 99th meeting of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. May 29th and 30th, 2003. Borer J; Armstrong P; Circulation; 2003 Jun; 107(23):e9052. PubMed ID: 12814989 [No Abstract] [Full Text] [Related]
33. Evaluation of ketoconazole. Sohn CA Clin Pharm; 1982; 1(3):217-24. PubMed ID: 6309466 [TBL] [Abstract][Full Text] [Related]
34. Ponatinib (Inclusig) marketing and sales suspended. Med Lett Drugs Ther; 2013 Nov; 55(1430):93. PubMed ID: 24276500 [No Abstract] [Full Text] [Related]